Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events
Kymberly D. Watt, Chun Fan, Terry Therneau, Julie K. Heimbach, Eric C. Seaberg, Michael R. Charlton – 2 April 2014 – In the nontransplant setting, aberrant serum adipokine levels are associated with cardiovascular (CV) disease. The effects of liver transplantation (LT) on serum adipokine levels and their association with post‐LT CV disease have not been studied.